The largest database of trusted experimental protocols

Tmp smx

Manufactured by Merck Group
Sourced in United States

TMP-SMX is a laboratory product manufactured by Merck Group. It is a combination of two antimicrobial agents, trimethoprim and sulfamethoxazole, which are used in clinical settings. The core function of TMP-SMX is to serve as a tool for research and diagnostic applications in the life sciences and healthcare industries.

Automatically generated - may contain errors

3 protocols using tmp smx

1

Antibiotic Susceptibility Profiling of E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wildtype strains E. cloni 10G and E. coli DH10B were inoculated in 20 ml of LB medium and incubated o/n at 37°C. The cell density was then adjusted to OD600 = 1 using fresh LB medium. Subsequently, aliquots of 100 μl of the liquid culture were plated out on LB agar plates containing increasing amounts of the antibiotics TOB (Sigma), CIP (Fluka), and TMP-SMX (Sigma). After 24 h of incubation at 37°C, the agar plates were examined for grown colonies.
MIC in liquid LB medium was determined as follows. Aliquots of 5 ml of LB medium containing increasing amounts of antibiotic were inoculated with an overnight culture of the test strains to an initial OD600 of 0.01. After incubation o/n at 37°C, the OD600 was measured.
+ Open protocol
+ Expand
2

Herbal Extracts Evaluation for Antiprotozoal Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The herbal extract with the highest efficacy and comparable results to MTZ was further fractionized into water and ethyl acetate fractions. Growth profile studies with the purified fractions were carried across ST1, ST3 and ST5 at 0.1 mg/ml and 1.0 mg/ml. Along with this, allopathic drugs MTZ, Tinidazole, TMP-SMX, Ketoconazole and Nitazoxanide (Sigma-Aldrich, USA) that are commonly associated as first and second line treatment, were also evaluated for its response across ST1, ST3 and ST5 at the same concentrations.
+ Open protocol
+ Expand
3

Antibiotic Susceptibility in S. maltophilia

Check if the same lab product or an alternative is used in the 5 most similar protocols
MICs were determined by agar dilution methods according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) (26 ). The following antibiotics/inhibitors were included: trimethoprim-sulfamethoxazole (TMP-SMX; Sigma, St. Louis, MO), ciprofloxacin (CIP; Fluka, Buchs, Switzerland), minocycline (MIN; Sigma, St. Louis, MO), ticarcillin-clavulanate (TIC-CLV; Sigma, St. Louis, MO), ceftazidime (CAZ; Sigma, St. Louis, MO), aztreonam (ATM; Bristol-Myers Squibb, New York, NY), and ceftazidime-avibactam (CZA) and ceftazidime-avibactam and aztreonam (CZA-ATM) combinations using the avibactam-free acid at a constant concentration of 4 g/liter from Advanced ChemBlock, Inc. (Burlingame, CA). Escherichia coli ATCC 25922 and ATCC 35218 were included as quality controls. Where breakpoints for S. maltophilia were not available, those for Pseudomonas aeruginosa were used, as has been previously done (13 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!